Press Releases from Austrianova (10 total)
Austrianova reports successful metronomic treatment using Cell-in-a-Box® in an …
SINGAPORE, December 19, 2023 - Austrianova, a member of the SGAustria group of companies, and a leading provider of cell encapsulated products as well as…
Austrianova announces German subsidiary and new location in Singapore
SINGAPORE, November 1st, 2023 - SG Austria ("Austrianova"), a leading provider of cell biological products and services, today announced that it has established a German…
Austrianova and ProAgni sign a licensing and manufacturing agreement for novel, …
Austrianova and ProAgni announced today the signing of a licensing and manufacturing agreement that foresees an intensification of joint activities between the two companies in…
Austrianova and San Raffaele University & Research Hospital announce the initiat …
The group of Dr. Matteo Bellone, group leader Cellular immunology Unit at San Raffaele University & Research Hospital, has shown that Prevotella melaninogenica, a commensal…
Austrianova secures Investment from Checkmate Capital
SINGAPORE, March 02, 2023 (GLOBE NEWSWIRE) -- SG Austria ("Austrianova"), a leading provider of cell biological products and services, today announced that Checkmate Capital Group…
Austrianova focuses relentlessly on excellence
SINGAPORE, April 21st, 2022
Austrianova (the SG Austria group, Austrianova Singapore and Austrianova Thailand) is pleased to announce that it has been awarded ISO 9001:2015 certification…
Austrianova Secures Significant Investment from Real Tech Fund
Austrianova (the SG Austria group, Austrianova Singapore and Austrianova Thailand) is pleased and honoured to announce that, after extensive due diligence, Real Tech Fund (managed…
Complete protection of probiotics from destruction by stomach acid using Bac-in- …
Austrianova announced today that a key publication on the ability of its patented technology, Bac-in-a-Box, to completely protect probiotics from acidic conditions found in…
Austrianova files Drug Master File with FDA
S.E. Asian company, Austrianova, headquartered in Singapore, announced today that it has filed a Drug Master File (DMF) with the U.S. Food and Drug Administration…
Cells for Cells and Austrianova announce publication on novel method to produce …
Austrianova and Cells for Cells have just jointly published a ground breaking, peer reviewed,
scientific publication on a novel, cost and time-saving method to generate extra-cellular…
Go To Page:
